Skip to content

Alismataceae

Tóm tắt

Họ Alismataceae2 chi được các cộng đồng sử dụng trong chăm sóc sức khỏe gồm Alisma, Sagittaria. Số lượng thành phần hóa học đã phân lập và xác định cấu trúc từ họ này tính đến tháng 12 năm 2024 là 7 nhóm có thể liệt kê như sau Steroids and steroid derivatives, Organooxygen compounds, Fatty Acyls, Indoles and derivatives, Pyrimidine nucleosides, Carboxylic acids and derivatives, Prenol lipids. Giữa các loài trong họ này, 3 dược liệu được nghiên cứu nhiều nhất dựa trên số thành phần được phân lập là Alisma plantago, Sagittaria sagittifolia. Họ Alismataceae đã được một số công động tại các quốc gia như Japan, China, Elsewhere, Turkey, Haiti, Egypt đã phát hiện một số tác dụng trên lâm sàng gồm chữa bệnh lẫn độc tính như Bàng quang, Chất làm se, Chất độc, Thuốc lợi tiểu, Chất làm se, Họ sẽ thảo luận, Họ sẽ thảo luận, Chất làm se, Chất làm se, Họ sẽ thảo luận, Thuốc lợi tiểu, Thuốc lợi tiểu, Thuốc lợi tiểu, Chất làm lạnh, Chất làm lạnh, dạ dày, Thuốc bổ, Chất làm se, Thuốc lợi tiểu, Chất độc, Chất làm se, cầm máu, Chất độc, có mùi hôi, Thuốc lợi tiểu, Làm dịu, Thuốc lợi tiểu, diệt khuẩn.

DrDuke

James A. Duke sinh năm 1929-2017 là một nhà thực vật học người Mỹ. Đây là một trong những tác giả hàng đầu trong lĩnh vực dược dân tộc học với cuốn CRC Handbook of Medicinal Herbs và chính là người xây dựng lên cơ sở dữ liệu về hợp chất tự nhiên và dược dân tộc học tại Bộ nông nghiệp Hoa Kỳ. Các thông tin được đăng tải tại website Dr. Duke's Phytochemical and Ethnobotanical Databases. Trong suốt thập niên 1970, ông lãnh đạo the Plant Taxonomy Laboratory, Plant Genetics and Germplasm Institute of the Agricultural Research Service, U.S. Department of Agriculture. Trong tài liệu này, các thông tin về dược dân tộc của các dược liệu được trích dẫn từ tài liệu của James A. Ducke với sự trợ giúp của phần mềm dịch thuật từ tiếng Anh sang tiếng Việt.

Tổng quan về Họ Alismataceae

Phân loại thực vật

Trong họ Alismataceae2 chi được sử dụng làm thuốc với chi tiết số loài trong mỗi chi như sau Sagittaria (2) . Chi tiết về loài sử dụng làm thuốc như dưới đây.

Họ Alismataceae

|-- Chi Alisma

Alisma gramineum, Alisma orientale, Alisma plantago, Alisma plantagoaquatica,

|-- Chi Sagittaria

Sagittaria lancifolia, Sagittaria sagittifolia,

Thành phần hóa học

Số lượng thành phần hóa học đã phân lập và xác định cấu trúc từ họ này tính đến tháng 12 năm 2024 là 7 nhóm có thể liệt kê như sau Steroids and steroid derivatives, Organooxygen compounds, Fatty Acyls, Indoles and derivatives, Pyrimidine nucleosides, Carboxylic acids and derivatives, Prenol lipids. Số lượng các loài đã được nghiên cứu thành phần hóa học là 2 trong tổng số 6 loài thuộc họ Alismataceae.Giữa các loài trong họ này, 3 dược liệu được nghiên cứu nhiều nhất dựa trên số thành phần được phân lập là Alisma plantago, Sagittaria sagittifolia. Sử dụng phần mềm RDKIT với thuật toán Find Maximum Common Substructure (FMCS), các nhóm hoạt chất phổ biến nhất trong họ Alismataceae đã xây dựng được nhân. Điều này trong tương lại có thể được sử dụng tìm kiếm mối liên hệ giữa tác dụng của cấu trúc hóa học và tác dụng dược lý. Các nhân trong phần này có thể không giống như cấu trúc gốc của từng nhóm chất. Kết quả được trình bầy như hình dưới đây.

 Cấu trúc hóa học của một số khung cơ bản dựa trên thuật toán FMCS để tìm Carboxylic acids and derivatives (A), Prenol lipids (B).
Cấu trúc hóa học của một số khung cơ bản dựa trên thuật toán FMCS để tìm Carboxylic acids and derivatives (A), Prenol lipids (B).

Find Maximum Common Substructure

Thuật toán FMCS (Find Maximum Common Substructure) là một phương pháp được sử dụng để tìm ra cấu trúc chung nhiều nhất (MCS) trong một tập hợp các cấu trúc hóa học. Các bước của thuật toán gồm: - Chọn một cấu trúc hóa học là cấu trúc để tạo truy vấn, còn các cấu trúc khác là mục tiêu. - Chia nhỏ cấu trúc để tạo truy vấn thành cấu trúc nhỏ hơn dạng chuỗi SMARTS. - Kiểm tra chuỗi SMARTS trong các cấu trúc mục tiêu. - Tìm kiếm chuỗi SMARTS xuất hiện nhiều nhất. Để biết thêm chi tiết các bạn có thể xem tại TeachOpenCADD

pip install rdkit
def find_core_smiles(smiles_list):
    mols = [Chem.MolFromSmiles(smiles) for smiles in smiles_list]
    mcs = rdFMCS.FindMCS(mols)
    core_smiles = Chem.MolToSmiles(Chem.MolFromSmarts(mcs.smartsString))
    return core_smiles

Dược dân tộc học

Họ Alismataceae đã được một số công động tại các quốc gia như Japan, China, Elsewhere, Turkey, Haiti, Egypt đã phát hiện một số tác dụng trên lâm sàng gồm chữa bệnh lẫn độc tính như Bàng quang, Chất làm se, Chất độc, Thuốc lợi tiểu, Chất làm se, Họ sẽ thảo luận, Họ sẽ thảo luận, Chất làm se, Chất làm se, Họ sẽ thảo luận, Thuốc lợi tiểu, Thuốc lợi tiểu, Thuốc lợi tiểu, Chất làm lạnh, Chất làm lạnh, dạ dày, Thuốc bổ, Chất làm se, Thuốc lợi tiểu, Chất độc, Chất làm se, cầm máu, Chất độc, có mùi hôi, Thuốc lợi tiểu, Làm dịu, Thuốc lợi tiểu, diệt khuẩn*.

Chi tiết dược dân tộc học

Chi Alisma

Danh sách các loài thuộc chi

    • Alisma gramineum
    • Alisma orientale
    • Alisma plantago
    • Alisma plantago-aquatica*

Sagittaria sagittifolia

Thông tin về thực vật

Phân loại thực vật của Sagittaria sagittifolia từ GIBF:

  • Kingdom: Plantae
  • Phylum: Tracheophyta
  • Order: Alismatales
  • Family: Alismataceae
  • Genus: Sagittaria
  • Species: Sagittaria sagittifolia

Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh

Chưa có thông tin về loài này trên wikidata.

Phân bố trên thế giới: Germany, Poland, Switzerland, Russian Federation, Estonia, Hong Kong, Lithuania, United Kingdom of Great Britain and Northern Ireland, Finland, Netherlands, Austria, Ukraine, Ireland, Belgium

Phân bố tại Việt Nam: Không có ghi nhận ở Việt Nam

Thành phần hóa học

Chưa có nghiên cứu về thành phần hóa học của loài này

Dược dân tộc học

Danh sách các quốc gia có sử dụng Sagittaria sagittifolia trong điều trị các bệnh.

Quốc gia Bệnh
Egypt Chất làm se, Chất độc, Thuốc lợi tiểu

Sagittaria sagittifolia

Thông tin về thực vật

Phân loại thực vật của Sagittaria sagittifolia từ GIBF:

  • Kingdom: Plantae
  • Phylum: Tracheophyta
  • Order: Alismatales
  • Family: Alismataceae
  • Genus: Sagittaria
  • Species: Sagittaria sagittifolia

Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh

Chưa có thông tin về loài này trên wikidata.

Phân bố trên thế giới: Germany, Poland, Switzerland, Russian Federation, Estonia, Hong Kong, Lithuania, United Kingdom of Great Britain and Northern Ireland, Finland, Netherlands, Austria, Ukraine, Ireland, Belgium

Phân bố tại Việt Nam: Không có ghi nhận ở Việt Nam

Thành phần hóa học

Chưa có nghiên cứu về thành phần hóa học của loài này

Dược dân tộc học

Danh sách các quốc gia có sử dụng Sagittaria sagittifolia trong điều trị các bệnh.

Quốc gia Bệnh
Japan* Thuốc lợi tiểu

Alisma plantago

Thông tin về thực vật

Phân loại thực vật của Alisma plantago-aquatica từ GIBF:

  • Kingdom: Plantae
  • Phylum: Tracheophyta
  • Order: Alismatales
  • Family: Alismataceae
  • Genus: Alisma
  • Species: Alisma plantago-aquatica

Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh

Chưa có thông tin về loài này trên wikidata.

Phân bố trên thế giới: France, Germany, nan, Korea, Republic of, Chile, Bulgaria, Egypt, Spain, Poland, Sweden, Japan, Belarus, Korea (Democratic People’s Republic of), Estonia, United Kingdom of Great Britain and Northern Ireland, India, Ukraine, United States of America, China, Lithuania, Italy, Canada, Iran (Islamic Republic of), Armenia, Austria, Belgium

Phân bố tại Việt Nam: Không có ghi nhận ở Việt Nam

Thành phần hóa học

Theo cơ sở dữ liệu lotus, từ loài Alisma plantago đã phân lập và xác định được 200 hoạt chất thuộc về các nhóm Steroids and steroid derivatives, Organooxygen compounds, Fatty Acyls, Pyrimidine nucleosides, Prenol lipids. Danh sách các hoạt chất như sau (1s,2r,4s,6r,7s,9r,13s,14s,15s,20r)-13-hydroxy-6-(2-hydroxypropan-2-yl)-1,2,9,15,19,19-hexamethyl-18-oxo-5-oxapentacyclo[12.8.0.0²,¹¹.0⁴,¹⁰.0¹⁵,²⁰]docos-10-en-7-yl acetate (LTS0264858), 5-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybutan-2-yl]-9-hydroxy-1,2,11,15,15-pentamethyl-6-oxapentacyclo[8.8.0.0²,⁷.0⁵,⁷.0¹¹,¹⁶]octadecan-14-one (LTS0054079), (1s,2s,7r,9r)-4-isopropyl-7,9-dimethyl-8-oxatricyclo[5.4.0.0²,⁹]undec-3-ene (LTS0244552), (1s,3r)-1-[(2r)-3,3-dimethyloxiran-2-yl]-3-[(1s,2r,5r,7r,9s,10s,11s,16s)-9-hydroxy-1,2,11,15,15-pentamethyl-14-oxo-6-oxapentacyclo[8.8.0.0²,⁷.0⁵,⁷.0¹¹,¹⁶]octadecan-5-yl]butyl acetate (LTS0062801), (1s,2r,4s,6s,8r,12s,13s,14s,19r)-6-[(1r)-1,2-dihydroxy-2-methylpropyl]-12-hydroxy-1,2,8,14,18,18-hexamethyl-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicos-9-en-17-one (LTS0235337), (3ar,3bs,5ar,9as,9bs,10s)-1-[(2r,4s,5r)-4,5-dihydroxy-6-methoxy-6-methylheptan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0120526), (1s,3ar,4r,8as)-4-(hydroxymethyl)-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulene-1,4-diol (LTS0045244), (3ar,3bs,5ar,9as,9br)-1-{4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl}-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0059312), (1s,2s,5r,6s,7r,8s)-7-hydroxy-8-isopropyl-1,5-dimethyl-11-oxatricyclo[6.2.1.0²,⁶]undecane-5-sulfonic acid (LTS0180408), (3ar,3bs,5as,9as,9bs,10s)-1-[(2r,4s,5s)-4,5-dihydroxy-6-methylhept-6-en-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0272682), alisol b (LTS0142354), (1s,4r)-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1,4-diol (LTS0065343), (3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0224429), (1s,3r)-3-[(3ar,3bs,5as,9ar,9bs)-3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0019296), [(1s,3as,4r,8as)-1,4-dihydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-yl]methanesulfonic acid (LTS0222590), (3s,5r)-5-[(1s,3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,9bh,10h-cyclopenta[a]phenanthren-1-yl]-3-hydroxy-2,2-dimethylhexanoic acid (LTS0236500), (1as,4ar,7s,7ar,7bs)-1a-isopropyl-7-methyl-4-methylidene-hexahydro-2h-azuleno[4,5-b]oxiren-7-ol (LTS0268493), (1s,3r)-3-[(3ar,3bs,5ar,9as,9bs,10r,11s)-10,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0073492), 3-hydroxy-5-{10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,8h,9h,9bh,10h-cyclopenta[a]phenanthren-1-yl}-2,2-dimethylhexanoic acid (LTS0244457), (1s,3as,8as)-7-isopropyl-1-methyl-4-methylidene-2,3,3a,5,6,8a-hexahydroazulen-1-ol (LTS0221661), (3ar,3bs,9as,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2r,4s,5s)-4,5,6-trihydroxy-6-methylheptan-2-yl]-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0063953), 6-(1,4b,8,8,10a-pentamethyl-2,7-dioxo-4a,5,6,8a,9,10-hexahydrophenanthren-1-yl)-1-(3,3-dimethyloxiran-2-yl)-3-methyl-4-oxohexyl acetate (LTS0255826), (1s,3r)-1-[(2r)-3,3-dimethyloxiran-2-yl]-3-[(1s,2r,4r,6s,10s,11s,16r)-1,2,11,15,15-pentamethyl-9,14-dioxo-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadec-7-en-6-yl]butyl acetate (LTS0192225), (3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0067170), (1s,3r)-3-[(3ar,3bs,5ar,7s,9as,9bs,10s)-7,10-dihydroxy-3a,3b,6,6,9a-pentamethyl-8-oxo-2h,3h,4h,5h,5ah,7h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0261806), (3s,4s,6r)-6-[(3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dihydroxy-2-methylheptan-4-yl acetate (LTS0204684), (1s,3'r,3ar,3bs,5ar,9as,9bs)-3',3a,3b,6,6,9a-hexamethyl-2,3,4,5,5a,8,9,9b-octahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxolane]-5',7,10-trione (LTS0243435), (3s,4s,6r)-6-[(3ar,3bs,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dihydroxy-2-methylheptan-4-yl acetate (LTS0033765), (3ar,3bs,9ar)-1-[(2r)-6-hydroxy-6-methyl-4-oxoheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione (LTS0149923), [(1r,4e)-1-hydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-ylidene]methanesulfonic acid (LTS0212006), (3ar,3bs,5as,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0202390), (3as,3br,5as,9ar,9br,10r)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2s,4r,5s)-4,5,6-trihydroxy-6-methylheptan-2-yl]-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione (LTS0154167), 4-isopropyl-1,7-dimethylcyclodeca-1,3,7-triene (LTS0274739), (1s,2r,4s,6s,8r,13s,14s,19r)-6-[(1r)-1,2-dihydroxy-2-methylpropyl]-1,2,8,14,18,18-hexamethyl-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicosa-9,11-dien-17-one (LTS0001687), 1-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybutan-2-yl]-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione (LTS0014570), (3ar,3bs,5as,9ar,9bs)-1-[(2r,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0214759), (3as,3bs,5ar,9as,9bs)-3a,3b,6,6,9a-pentamethyl-1-[(2r,4s,5s)-4,5,6-trihydroxy-6-methylheptan-2-yl]-3h,5h,5ah,8h,9h,9bh-cyclopenta[a]phenanthrene-2,4,7-trione (LTS0172188), (1s,3r)-3-[(3ar,3bs,9as,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0216826), 7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1,4-diol (LTS0093076), (1s,3r)-3-[(3ar,3bs,5as,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0267461), (1s,2r,5r,7r,10s,11r,16s)-1,2,11,15,15-pentamethyl-5-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-6-oxapentacyclo[8.8.0.0²,⁷.0⁵,⁷.0¹¹,¹⁶]octadecan-14-one (LTS0159933), (3s,4s,6r)-6-[(3ar,3bs,5ar,9as,9bs)-3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh-cyclopenta[a]phenanthren-1-yl]-2,3-dihydroxy-2-methylheptan-4-yl acetate (LTS0029147), (1s,3r)-6-[(1r,4as,4bs,8ar,10as)-1,4b,8,8,10a-pentamethyl-2,7-dioxo-4a,5,6,8a,9,10-hexahydrophenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]-3-methyl-4-oxohexyl acetate (LTS0065296), 3-{3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh-cyclopenta[a]phenanthren-1-yl}-1-(3,3-dimethyloxiran-2-yl)butyl acetate (LTS0159684), (1as,7s,7bs)-1a-isopropyl-7-methyl-4-methylidene-hexahydro-2h-azuleno[4,5-b]oxiren-7-ol (LTS0108103), 10-hydroxy-3a,3b,6,6,9a-pentamethyl-1-(4,5,6-trihydroxy-6-methylheptan-2-yl)-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0195603), [(1r,3as,4s,8ar)-1,4-dihydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-yl]methanesulfonic acid (LTS0021874), (1s,2r,8r,12s,14s)-6-[(1r)-1,2-dihydroxy-2-methylpropyl]-12-hydroxy-1,2,8,14,18,18-hexamethyl-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicos-9-en-17-one (LTS0050194), (3r,4r,5s,6r)-6-(hydroxymethyl)-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-2,3,4-triol (LTS0270269), (1s,3r)-3-[(3ar,3bs,9as)-3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0135235), 2-methyl-2-[(1s,5s,6r,9s,10r,16s)-5,9,10-trimethyl-3-oxo-13-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadec-13-en-6-yl]propanoic acid (LTS0049002), (1r,3as,8ar)-7-isopropyl-1-methyl-4-methylidene-2,3,3a,5,6,8a-hexahydroazulen-1-ol (LTS0166280), (1s,3as)-7-isopropyl-1-methyl-4-methylidene-2,3,3a,5,6,8a-hexahydroazulen-1-ol (LTS0133745), 2-[(1s,5s,9s,10r)-13-[(2r,4s)-4-(acetyloxy)-4-[(2r)-3,3-dimethyloxiran-2-yl]butan-2-yl]-5,9,10-trimethyl-3-oxo-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadec-13-en-6-yl]-2-methylpropanoic acid (LTS0190214), (1r)-1-[(1s,2r,4s,6s,8r,13s,14s,19r)-1,2,8,14,18,18-hexamethyl-17-oxo-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicosa-9,11-dien-6-yl]-2-hydroxy-2-methylpropyl acetate (LTS0033412), 1-(6-hydroxy-6-methyl-4-oxoheptan-2-yl)-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione (LTS0258739), [(1s,4e)-1-hydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-ylidene]methanesulfonic acid (LTS0200057), (3s,4s,6r)-6-[(3ar,3bs,9as,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dihydroxy-2-methylheptan-4-yl acetate (LTS0140176), 7-isopropyl-4-methoxy-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulen-1-ol (LTS0135904), (1s,4r)-4-(hydroxymethyl)-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulene-1,4-diol (LTS0051019), (3ar,3bs,5ar,9as,9bs)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(4s)-4,5,6-trihydroxy-6-methylheptan-2-yl]-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0129085), (1r,4r,9r,10r,13r,14r)-5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-7,12-dione (LTS0104543), (3s,4s,6r)-6-[(3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-4-hydroxy-2-methylheptan-3-yl acetate (LTS0185502), (3ar,3bs,5ar,9as,9bs,10s)-1-[(2r,4s,5r)-6-ethoxy-4,5-dihydroxy-6-methylheptan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0000783), (3ar,3bs,5ar,9as,9bs)-3a,3b,6,6,9a-pentamethyl-1-[(2r,4s,5s)-4,5,6-trihydroxy-6-methylheptan-2-yl]-3h,4h,5h,5ah,8h,9h,9bh-cyclopenta[a]phenanthrene-2,7-dione (LTS0092574), 3',3a,3b,6,6,9a-hexamethyl-2,3,4,5,5a,8,9,9b-octahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxolane]-5',7,10-trione (LTS0007303), 1-(3,3-dimethyloxiran-2-yl)-3-{10-hydroxy-2-methoxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}butyl acetate (LTS0106178), 3-[(3ar,9as,9bs)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-(3,3-dimethyloxiran-2-yl)butyl acetate (LTS0173368), (1s,3r)-3-[(3ar,3bs,5ar,9as,9bs,10r,11s)-10,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0162442), (3ar,3bs,5ar,9as,9bs)-1-[(2r,4s,5r)-4,5-dihydroxy-6-methylhept-6-en-2-yl]-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh-cyclopenta[a]phenanthrene-2,7-dione (LTS0051109), docosanol (LTS0250870), 7-hydroxy-8-isopropyl-1,5-dimethyl-11-oxatricyclo[6.2.1.0²,⁶]undecane-5-sulfonic acid (LTS0027278), [(1s,3as,4e,8as)-1-hydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-ylidene]methanesulfonic acid (LTS0041382), 1-(4,5-dihydroxy-6-methylhept-6-en-2-yl)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0244166), (1s,3r)-3-[(3ar,3bs,9as,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0011229), (1r,2s,5s,6r,7s,8r)-7-hydroxy-8-isopropyl-1,5-dimethyl-11-oxatricyclo[6.2.1.0²,⁶]undecane-5-sulfonic acid (LTS0079814), (1s,2r,4s,6r,7s,9r,13s,15s)-13-hydroxy-6-(2-hydroxypropan-2-yl)-1,2,9,15,19,19-hexamethyl-18-oxo-5-oxapentacyclo[12.8.0.0²,¹¹.0⁴,¹⁰.0¹⁵,²⁰]docos-10-en-7-yl acetate (LTS0151007), (1z,6z,8s)-8-isopropyl-1-methyl-5-methylidenecyclodeca-1,6-diene (LTS0065195), (6e,8s)-8-isopropyl-1-methyl-5-methylidenecyclodeca-1,6-diene (LTS0193756), 8-isopropyl-1,5-dimethyl-11-oxatricyclo[6.2.1.0²,⁶]undec-5-en-7-ol (LTS0139415), (1r,2r,7s,8r)-8-isopropyl-1,5-dimethyl-11-oxatricyclo[6.2.1.0²,⁶]undec-5-en-7-ol (LTS0202405), (1s,3as,4r,8as)-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1,4-diol (LTS0257229), (1r,3as,3br,5ar,9as)-1-[(2r,5s)-5,6-dihydroxy-6-methylheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-1h,2h,3h,4h,5h,5ah,8h,9h-cyclopenta[a]phenanthren-7-one (LTS0049169), methyl 2-[(1s,5s,9s,10r)-13-[(2r,4s)-4-(acetyloxy)-4-[(2r)-3,3-dimethyloxiran-2-yl]butan-2-yl]-5,9,10-trimethyl-3-oxo-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadec-13-en-6-yl]-2-methylpropanoate (LTS0047175), 2,3-dihydroxy-6-{10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylheptan-4-yl acetate (LTS0138205), 1-(3,3-dimethyloxiran-2-yl)-3-{9-hydroxy-1,2,11,15,15-pentamethyl-14-oxo-6-oxapentacyclo[8.8.0.0²,⁷.0⁵,⁷.0¹¹,¹⁶]octadecan-5-yl}butyl acetate (LTS0181013), (1s,2r,5r,6s,7s)-1,5-dimethyl-5-(propane-2-sulfonyl)-11λ⁶-thiatricyclo[5.3.1.0²,⁶]undecane-8,11,11-trione (LTS0273781), 4-(hydroxymethyl)-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulene-1,4-diol (LTS0061544), 8-isopropyl-1,5-dimethyl-11-oxatricyclo[6.2.1.0²,⁶]undecane-5,7-diol (LTS0269489), [(2r,3s,4s,5r,6r)-6-{[(1r,3as,3bs,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl octadecanoate (LTS0214964), (1r,3as,4s,8ar)-7-isopropyl-4-methoxy-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulen-1-ol (LTS0194618), (3ar,3bs,5ar,9ar,9bs)-1-[(2r,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione (LTS0142781), (3ar,3bs,5ar,9ar,9bs)-1-[(2r,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0102707), (1s,3r)-3-[(3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0058111), (1s,3as,4r,8as)-4-hydroxy-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1-sulfonic acid (LTS0257683), [(1s,4r)-1,4-dihydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-yl]methanesulfonic acid (LTS0267177), (3ar,3bs,5as,9as,9bs,10s)-1-[(2r,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0182358), 8-isopropyl-1-methyl-5-methylidenecyclodeca-1,6-diene (LTS0018398), 1-(3,3-dimethyloxiran-2-yl)-3-{1,2,11,15,15-pentamethyl-14-oxo-6-oxapentacyclo[8.8.0.0²,⁷.0⁵,⁷.0¹¹,¹⁶]octadecan-5-yl}butyl acetate (LTS0045997), 1-(3,3-dimethyloxiran-2-yl)-3-{10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}butyl acetate (LTS0144006), (1s,2r,4s,6s,7s,9r,13s,14s,15s,20r)-13-hydroxy-6-(2-hydroxypropan-2-yl)-1,2,9,15,19,19-hexamethyl-18-oxo-5-oxapentacyclo[12.8.0.0²,¹¹.0⁴,¹⁰.0¹⁵,²⁰]docos-10-en-7-yl acetate (LTS0159062), stigmast-5-en-3-ol, (3β)- (LTS0204616), [(4e)-1-hydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-ylidene]methanesulfonic acid (LTS0053632), 4-hydroxy-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1-sulfonic acid (LTS0196077), (3r,4s,6r)-6-[(3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,4-dihydroxy-2-methylheptan-3-yl acetate (LTS0145003), (3ar,9as,9bs)-1-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybutan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0044293), 3-{2,10-dihydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-(3,3-dimethyloxiran-2-yl)butyl acetate (LTS0211539), (1s,3r)-3-[(3ar,3bs,5as,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0061654), [(1r,4s)-1,4-dihydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-yl]methanesulfonic acid (LTS0110841), 1-(4,5-dihydroxy-6-methylheptan-2-yl)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0206845), (3r,4s,6r)-6-[(3ar,3bs,9as,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,4-dihydroxy-2-methylheptan-3-yl acetate (LTS0148559), (1s,3r)-3-[(3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0257510), (1s,2r,4s,6s,8r,12s,13s,14s,19r)-12-hydroxy-6-[(1s)-1-hydroxy-2-methylprop-2-en-1-yl]-1,2,8,14,18,18-hexamethyl-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicos-9-en-17-one (LTS0161694), (1s,5s,7s,8s)-7-hydroxy-8-isopropyl-1,5-dimethyl-11-oxatricyclo[6.2.1.0²,⁶]undecane-5-sulfonic acid (LTS0223153), (1s,3r)-3-[(3ar,3bs,5ar,9as,9bs)-3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0270744), (1s,3r)-3-[(2s,3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-2-methoxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0049033), galactitol (LTS0012947), (6-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl octadecanoate (LTS0005120), sitogluside (LTS0201798), (1-hydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-ylidene)methanesulfonic acid (LTS0039800), (3as,3br,5as,9ar,9br,10r)-1-[(2s,4r)-4-[(2s)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione (LTS0156220), (1s,3r)-1-[(2r)-3,3-dimethyloxiran-2-yl]-3-[(1s,2r,5r,7r,10s,11r,16s)-1,2,11,15,15-pentamethyl-14-oxo-6-oxapentacyclo[8.8.0.0²,⁷.0⁵,⁷.0¹¹,¹⁶]octadecan-5-yl]butyl acetate (LTS0039687), 1,2,11,15,15-pentamethyl-5-(4,5,6-trihydroxy-6-methylheptan-2-yl)-6-oxapentacyclo[8.8.0.0²,⁷.0⁵,⁷.0¹¹,¹⁶]octadecan-14-one (LTS0197481), (1r,3as,8ar)-7-isopropyl-4-methoxy-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulen-1-ol (LTS0235365), (3as,3br,5as,9as,9br)-1-[(2s,4r)-4-[(2s)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0256418), 5,5,9,14-tetramethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-7,12-dione (LTS0208163), 4-hydroxy-6-{10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylheptan-3-yl acetate (LTS0125514), 2,4-dihydroxy-6-{10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylheptan-3-yl acetate (LTS0120394), (1s,3r)-3-[(3ar,3bs,5as,9ar,9bs)-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0140537), (3ar,3bs,5ar,9as,9bs)-1-acetyl-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh-cyclopenta[a]phenanthrene-2,7-dione (LTS0221131), 4-isopropyl-7,9-dimethyl-8-oxatricyclo[5.4.0.0²,⁹]undec-3-ene (LTS0145855), (1s,3ar,8as)-7-isopropyl-1-methyl-4-methylidene-2,3,3a,5,6,8a-hexahydroazulen-1-ol (LTS0116683), (3ar,3bs,9ar)-1-[(2r,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0174572), 1-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybutan-2-yl]-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0196837), [(1r,3as,4e,8ar)-1-hydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-ylidene]methanesulfonic acid (LTS0065159), (3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2r,4s,5s)-4,5,6-trihydroxy-6-methylheptan-2-yl]-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0233416), 1-(4,5-dihydroxy-6-methoxy-6-methylheptan-2-yl)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0150393), (1s,2r,8r,14r)-6-[(2r)-3,3-dimethyloxiran-2-yl]-1,2,8,14,18,18-hexamethyl-5-oxapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁴,¹⁹]henicos-9-en-17-one (LTS0147641), (3ar,3bs,5as,9ar,9bs)-3a,3b,6,6,9a-pentamethyl-1-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0064826), 3a,3b,6,6,9a-pentamethyl-1-(4,5,6-trihydroxy-6-methylheptan-2-yl)-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0181395), 6-[(3ar,9as,9bs)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,4-dihydroxy-2-methylheptan-3-yl acetate (LTS0084389), 1-[(1r,3as,4s,7r,7ar)-4-hydroxy-7-isopropyl-4-methyl-octahydroinden-1-yl]ethanone (LTS0019650), (1,4-dihydroxy-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulen-4-yl)methanesulfonic acid (LTS0189543), (1s,3ar,4r,8ar)-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1,4-diol (LTS0086573), uridine (LTS0220125), (1s)-7-isopropyl-1-methyl-4-methylidene-2,3,3a,5,6,8a-hexahydroazulen-1-ol (LTS0076401), ergosterol (LTS0171131), 1-[4-(3,3-dimethyloxiran-2-yl)-4-hydroxybutan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0233818), 9-hydroxy-1,2,11,15,15-pentamethyl-5-(4,5,6-trihydroxy-6-methylheptan-2-yl)-6-oxapentacyclo[8.8.0.0²,⁷.0⁵,⁷.0¹¹,¹⁶]octadecan-14-one (LTS0236174), 7-isopropyl-1-methyl-4-methylidene-2,3,3a,5,6,8a-hexahydroazulen-1-ol (LTS0053636), (3ar,3bs,9as,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-1-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0154666), (1s,2r,5r,7r,9s,10s,11s,16s)-5-[(2r,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-9-hydroxy-1,2,11,15,15-pentamethyl-6-oxapentacyclo[8.8.0.0²,⁷.0⁵,⁷.0¹¹,¹⁶]octadecan-14-one (LTS0267093), 3-{3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-(3,3-dimethyloxiran-2-yl)butyl acetate (LTS0080778), (1s,3r)-3-[(3ar,3bs,5ar,9ar,9bs)-3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0095296), (3ar,3bs,5ar,9ar,9bs)-1-[(2r)-6-hydroxy-6-methyl-4-oxoheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione (LTS0002392), (3ar,3bs,5ar,9as,9bs,10s)-1-[(2r,4s,5s)-4,5-dihydroxy-6-methylhept-6-en-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0117702), (1s,2r,5r,7r,9s,10s,11s,16r)-9-hydroxy-1,2,11,15,15-pentamethyl-5-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-6-oxapentacyclo[8.8.0.0²,⁷.0⁵,⁷.0¹¹,¹⁶]octadecan-14-one (LTS0254313), (3ar,3bs,9as,10s)-1-[(2r,4s,5s)-4,5-dihydroxy-6-methylhept-6-en-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0091219), (1r,3as,4s,8ar)-4-hydroxy-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1-sulfonic acid (LTS0122625), (3ar,3bs,5ar,9ar,9bs)-1-[(2r,4s,5r)-4,5-dihydroxy-6-methylhept-6-en-2-yl]-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0172774), (3s,5r)-5-[(3ar,3bs,9as,9br,10s)-10-hydroxy-3a,6,6,9a-tetramethyl-7-oxo-2h,3h,3bh,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-3-(3,3-dimethyloxiran-2-yl)-3-hydroxyhexanoic acid (LTS0210428), (3s,4s,6r)-6-[(3ar,3bs,5ar,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,4-dihydroxy-2-methylheptan-3-yl acetate (LTS0212706), (3ar,3bs,5ar,9as,9bs,10s)-1-[(2s,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-2,4-dihydroxybutan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione (LTS0053564), (3r,4s,6r)-6-[(3ar,3bs,5as,9as,9bs,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,4-dihydroxy-2-methylheptan-3-yl acetate (LTS0180761), (-)-germacrene d (LTS0059194), 2-[(5s,6r,9s,10r,16s)-13-[(2r,4s)-4-(acetyloxy)-4-[(2r)-3,3-dimethyloxiran-2-yl]butan-2-yl]-5,9,10-trimethyl-3-oxo-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadec-13-en-6-yl]-2-methylpropanoic acid (LTS0264270), (1s,3r)-6-[(1r,4bs,10as)-1,4b,8,8,10a-pentamethyl-2,7-dioxo-4a,5,6,8a,9,10-hexahydrophenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]-3-methyl-4-oxohexyl acetate (LTS0113201), (1s,2r,4s,6r,9r,14s,15s,20r)-6-(2-hydroxypropan-2-yl)-1,2,9,15,19,19-hexamethyl-5-oxapentacyclo[12.8.0.0²,¹¹.0⁴,¹⁰.0¹⁵,²⁰]docosa-10,12-diene-7,18-dione (LTS0096086), (1s,5r,8s)-7-hydroxy-8-isopropyl-1,5-dimethyl-11-oxatricyclo[6.2.1.0²,⁶]undecane-5-sulfonic acid (LTS0160851), (-)-alismoxide (LTS0033374), (1s,3r)-3-[(3ar,3bs,5ar,9ar,9bs)-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0048807), (3ar,3bs,5ar,9ar,9bs)-3a,3b,6,6,9a-pentamethyl-1-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0138402), 2-methyl-2-[5,9,10-trimethyl-3-oxo-13-(4,5,6-trihydroxy-6-methylheptan-2-yl)-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadec-13-en-6-yl]propanoic acid (LTS0129039), (1r,3s)-3-[(3as,3br,5as,9ar,9br,10r)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2s)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0263392), (3ar,3bs,5as,9as,9bs,10s)-1-[(2r,4s,5r)-4,5-dihydroxy-6-methoxy-6-methylheptan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0112451), (1s,3s)-3-[(3as,3bs,5ar,9as,9br,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0043024), (3ar,3bs,9as,10s)-1-[(2r,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0197518), (-)-inositol (LTS0047771), (1s,3r)-1-[(2r)-3,3-dimethyloxiran-2-yl]-3-[(1s,2r,4s,6r,11s)-1,2,11,15,15-pentamethyl-9,14-dioxo-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadec-7-en-6-yl]butyl acetate (LTS0197001), (2r,3s,4s,5r)-2,5-bis(hydroxymethyl)-2-methoxyoxolane-3,4-diol (LTS0191480), 3-{3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-(3,3-dimethyloxiran-2-yl)butyl acetate (LTS0139866), (1s,3r)-3-[(3ar,3bs,9as,10r,11s)-10,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0231814), 3-[(3ar,3bs,9as,10s)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-(3,3-dimethyloxiran-2-yl)butyl acetate (LTS0050353), (1r,2r,5s,6r,7s,8r)-8-isopropyl-1,5-dimethyl-11-oxatricyclo[6.2.1.0²,⁶]undecane-5,7-diol (LTS0116623), (3ar,3bs,5ar,9as,9bs,10s)-1-[(2r,4s,5s)-4,5-dihydroxy-6-methylheptan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0047663), (1s,3r)-3-[(3ar,3bs,9as,10r,11s)-10,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0171789), (1r,3as,8as)-7-isopropyl-1-methyl-4-methylidene-2,3,3a,5,6,8a-hexahydroazulen-1-ol (LTS0162326), thymidine (LTS0162810), 3-[(3ar,3bs,5ar,9as,9br)-10-hydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0228361), (1s,3ar,4r,8as)-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1,4-diol (LTS0093037), (3as,3bs,5ar,9as,9br,10s)-1-[(2s,4s)-4-[(2r)-3,3-dimethyloxiran-2-yl]-4-hydroxybutan-2-yl]-10-hydroxy-3a,3b,6,6,9a-pentamethyl-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one (LTS0028489), (1s,3r)-1-[(2r)-3,3-dimethyloxiran-2-yl]-3-[(1s,2r,4s,6r,10s,11s,16r)-1,2,11,15,15-pentamethyl-9,14-dioxo-5-oxapentacyclo[8.8.0.0²,⁷.0⁴,⁶.0¹¹,¹⁶]octadec-7-en-6-yl]butyl acetate (LTS0070516), (1r,4s)-4-hydroxy-7-isopropyl-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulene-1-sulfonic acid (LTS0175809), (1s,3r)-3-[(2s,3ar,3bs,5ar,9as,9bs,10s)-2,10-dihydroxy-3a,3b,6,6,9a-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r)-3,3-dimethyloxiran-2-yl]butyl acetate (LTS0125357), (3ar,3bs,5as,9as,9bs,10s)-10-hydroxy-3a,3b,6,9a-tetramethyl-1-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-2h,3h,4h,5h,5ah,9h,9bh,10h,11h-cyclopenta[a]phenanthren-8-one (LTS0122678), (3ar,3bs,5ar,9as,9bs)-1-[(2r,5r)-5,6-dihydroxy-6-methyl-4-oxoheptan-2-yl]-3a,3b,6,6,9a-pentamethyl-3h,4h,5h,5ah,8h,9h,9bh-cyclopenta[a]phenanthrene-2,7-dione (LTS0274606), 1-(3,3-dimethyloxiran-2-yl)-3-{10-hydroxy-3a,3b,6,6,9a-pentamethyl-2,7-dioxo-3h,4h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}butyl acetate (LTS0163299), germacrene c (LTS0161450), 1a-isopropyl-7-methyl-4-methylidene-hexahydro-2h-azuleno[4,5-b]oxiren-7-ol (LTS0216626), (1s,3ar,4s,8as)-4-(hydroxymethyl)-7-isopropyl-1-methyl-2,3,3a,5,6,8a-hexahydroazulene-1,4-diol (LTS0237272).

chemicalTaxonomyClassyfireClass lotus_count
Fatty Acyls 1
Organooxygen compounds 4
Prenol lipids 41
Pyrimidine nucleosides 2
Steroids and steroid derivatives 5

Dược dân tộc học

Danh sách các quốc gia có sử dụng Alisma plantago-aquatica trong điều trị các bệnh.

Quốc gia Bệnh
China Chất làm se, Họ sẽ thảo luận, Thuốc lợi tiểu, Thuốc lợi tiểu, Thuốc lợi tiểu, Chất làm lạnh, Chất làm lạnh, dạ dày, Thuốc bổ
Turkey Chất làm se, cầm máu, Chất độc, có mùi hôi, Thuốc lợi tiểu

Alisma plantago

Thông tin về thực vật

Phân loại thực vật của Alisma plantago-aquatica từ GIBF:

  • Kingdom: Plantae
  • Phylum: Tracheophyta
  • Order: Alismatales
  • Family: Alismataceae
  • Genus: Alisma
  • Species: Alisma plantago-aquatica

Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh

Chưa có thông tin về loài này trên wikidata.

Phân bố trên thế giới: France, Germany, nan, Korea, Republic of, Chile, Bulgaria, Egypt, Spain, Poland, Sweden, Japan, Belarus, Korea (Democratic People’s Republic of), Estonia, United Kingdom of Great Britain and Northern Ireland, India, Ukraine, United States of America, China, Lithuania, Italy, Canada, Iran (Islamic Republic of), Armenia, Austria, Belgium

Phân bố tại Việt Nam: Không có ghi nhận ở Việt Nam

Thành phần hóa học

Chưa có nghiên cứu về thành phần hóa học của loài này

Dược dân tộc học

Danh sách các quốc gia có sử dụng Alisma plantago-aquatica trong điều trị các bệnh.

Quốc gia Bệnh
China diệt khuẩn
Egypt Chất làm se, Thuốc lợi tiểu, Chất độc

Chi Sagittaria

Danh sách các loài thuộc chi

    • Sagittaria lancifolia
    • Sagittaria sagittifolia*

Alisma plantago

Thông tin về thực vật

Phân loại thực vật của Alisma plantago-aquatica từ GIBF:

  • Kingdom: Plantae
  • Phylum: Tracheophyta
  • Order: Alismatales
  • Family: Alismataceae
  • Genus: Alisma
  • Species: Alisma plantago-aquatica

Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh

Chưa có thông tin về loài này trên wikidata.

Phân bố trên thế giới: France, Germany, nan, Korea, Republic of, Chile, Bulgaria, Egypt, Spain, Poland, Sweden, Japan, Belarus, Korea (Democratic People’s Republic of), Estonia, United Kingdom of Great Britain and Northern Ireland, India, Ukraine, United States of America, China, Lithuania, Italy, Canada, Iran (Islamic Republic of), Armenia, Austria, Belgium

Phân bố tại Việt Nam: Không có ghi nhận ở Việt Nam

Thành phần hóa học

Chưa có nghiên cứu về thành phần hóa học của loài này

Dược dân tộc học

Danh sách các quốc gia có sử dụng Alisma plantago-aquatica trong điều trị các bệnh.

Quốc gia Bệnh
Haiti Bàng quang

Sagittaria sagittifolia

Thông tin về thực vật

Phân loại thực vật của Sagittaria sagittifolia từ GIBF:

  • Kingdom: Plantae
  • Phylum: Tracheophyta
  • Order: Alismatales
  • Family: Alismataceae
  • Genus: Sagittaria
  • Species: Sagittaria sagittifolia

Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh Mô tả hình ảnh

Chưa có thông tin về loài này trên wikidata.

Phân bố trên thế giới: Germany, Poland, Switzerland, Russian Federation, Estonia, Hong Kong, Lithuania, United Kingdom of Great Britain and Northern Ireland, Finland, Netherlands, Austria, Ukraine, Ireland, Belgium

Phân bố tại Việt Nam: Không có ghi nhận ở Việt Nam

Thành phần hóa học

Theo cơ sở dữ liệu lotus, từ loài Sagittaria sagittifolia đã phân lập và xác định được 31 hoạt chất thuộc về các nhóm Steroids and steroid derivatives, Prenol lipids, Indoles and derivatives, Carboxylic acids and derivatives. Danh sách các hoạt chất như sau (2r,3r,4r,5s)-2-{[(1s,4ar,4bs,7s,8as)-7-ethenyl-1,4b,7-trimethyl-3,4,4a,5,6,8,8a,9-octahydro-2h-phenanthren-1-yl]methoxy}-5-(hydroxymethyl)oxolane-3,4-diol (LTS0188056), 2-{[1-(5-ethyl-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol (LTS0158828), d-aspartic acid (LTS0144001), (2s)-2-(phenylamino)propanoic acid (LTS0199539), d-phenylalanine (LTS0048920), l-alanine (LTS0042208), d-alanine (LTS0272178), l-lysine (LTS0068734), (2r,3r,4s,5s)-2-{[(1s,4ar,4bs,7s,8as)-7-ethenyl-1,4b,7-trimethyl-3,4,4a,5,6,8,8a,9-octahydro-2h-phenanthren-1-yl]methoxy}-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl acetate (LTS0176523), 5-[2-(hydroxymethyl)-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-1-en-3-ol (LTS0081213), l-aspartic acid (LTS0205466), l-serine (LTS0106692), l-histidine (LTS0094081), l-tyrosine (LTS0029981), l-proline (LTS0090383), [(2s,3s,4r,5r)-5-{[(1s,4ar,4bs,7s,8as)-7-ethenyl-1,4b,7-trimethyl-3,4,4a,5,6,8,8a,9-octahydro-2h-phenanthren-1-yl]methoxy}-4-(acetyloxy)-3-hydroxyoxolan-2-yl]methyl acetate (LTS0067151), d-methionine (LTS0108782), l-valine (LTS0231703), l-arginine (LTS0064737), (2r)-1-[2-(hydroxymethyl)-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-2-methylbut-3-en-2-ol (LTS0194276), l-threonine (LTS0184056), (1s,4ar,4bs,7s,8as)-7-ethenyl-1,4b,7-trimethyl-3,4,4a,5,6,8,8a,9-octahydro-2h-phenanthrene-1-carboxylic acid (LTS0115776), l-isoleucine (LTS0249538), l-glutamic acid (LTS0037133), [(2s,3r,4r,5r)-5-{[(1s,4ar,4bs,7s,8as)-7-ethenyl-1,4b,7-trimethyl-3,4,4a,5,6,8,8a,9-octahydro-2h-phenanthren-1-yl]methoxy}-3,4-dihydroxyoxolan-2-yl]methyl acetate (LTS0231876), l-tryptophan (LTS0263809), l-methionine (LTS0196746), (3s)-5-[(1r,4as,8as)-2-(hydroxymethyl)-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-1-en-3-ol (LTS0027869), (2r,3r,4s,5s,6r)-2-{[(1r,3ar,3br,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol (LTS0194482), 5-[5-(hydroxymethyl)-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-1-en-3-ol (LTS0229474), l-leucine (LTS0113423).

chemicalTaxonomyClassyfireClass lotus_count
Carboxylic acids and derivatives 19
Indoles and derivatives 1
Prenol lipids 8
Steroids and steroid derivatives 2

Dược dân tộc học

Danh sách các quốc gia có sử dụng Sagittaria sagittifolia trong điều trị các bệnh.

Quốc gia Bệnh
Elsewhere Chất làm se, Họ sẽ thảo luận, Họ sẽ thảo luận, Chất làm se
Turkey Làm dịu

Bình luận

Categories